The heart lesions of rheumatic fever and the heart involvement in antiphospholipid syndrome (APS), have different clinical pictures. Yet, there are several common characteristics linking both diseases: 1) central nervous system (CNS) and heart involvement; 2) molecular mimicry between the a pathogen and the origin of the disease; 3) cross reacting antibodies between the pathogen and self molecules; 4) endothelial cell activation in the ‘crime-area’ i.e., the valves; 5) some of the patients with RF have circulating antiphospholipid antibodies, while APS may be associated with streptococcal infection; and 6) recently, a cross-reactivity between antibodies directed to the streptococcal M-protein and its synthetic derivative in rheumatic fever (RF) and antibodies derived from APS patients targeting the beta-2-glycoprotein-I (β2GPI) and a β2GPI related synthetic peptide. In the current paper, we summarize the possible links between the heart involvement in RF and APS.
Bisno AL.Nonsuppurative poststreptococcal sequelae: rheumatic fever and glomerulonephritis. In Mandell GL , Bennett JE , Dolin R , eds. Principles and practice of infectious diseases, New York, USA: Churchill Livingston , 1995: 1799-1810.
2.
Dudding BA , Ayoub EM.Persistence of streptococcal group A antibody in patients with rheumatic valvular disease . J Exp Med1968; 128: 1081-1198 .
3.
Guilherme L , Cunha-Neto E , Coelho Vet al.Human heart-filtrating T cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins . Circulation1995; 92: 415-420 .
4.
Cunningham MW.Pathogenesis of group A streptococcal infections . Clin Microbiol Rev2000; 13: 470-511 .
5.
Roberts S , Kosanke S , Terrence Dunn S , Jankelow D , Duran CM , Cunningham MW.Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium . J Infect Dis2001; 18: 507-511 .
6.
Guilherme L , Cunha-Neto E , Tanaka AC , Dulphy N , Toubert A , Kalil J.Heart-directed autoimmunity: the case of rheumatic fever . J Autoimmun2001; 16: 363-367 .
7.
Guilherme L , Oshiro SE , Fae KCet al.T-cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart-infiltrating T lymphocytes in rheumatic heart disease patients . Infect Immun2001; 69: 5345-5351 .
8.
Fae K , Kalil J , Toubert A , Guilherme L.Heart infiltrating T cell clones from a rheumatic heart disease patient display a common TCR usage and a degenerate antigen recognition pattern . Mol Immunol2004; 40: 1129-1135 .
9.
Fae KC , Oshiro SE , Toubert A , Charron D , Kalil J , Guilherme L.How an autoimmune reaction triggered by molecular mimicry between streptococcal M protein and cardiac tissue proteins leads to heart lesions in rheumatic heart disease . J Autoimmun2005; 24: 101-109 .
10.
Guilherme L , Cury P , Demarchi LMet al.Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions . Am J Pathol2004; 165: 1583-1591 .
11.
Cunningham MW.Autoimmunity and molecular mimicry in the pathogenesis of post-streptococcal heart disease . Front Biosci2003; 8: 533-543 .
12.
Kaplan MH , Bolande R , Rakita L , Blair J.Presence of bound immunoglobulins and complement in the myocardium in acute rheumatic fever . N Engl J Med1964; 271: 637-645 .
13.
Cunningham MW , McCormack JM , Talaber LRet al.Human monoclonal antibodies reactive with antigens of the group A streptococcus and human heart . J Immunol1988; 141: 2760-2766 .
14.
Dale JB , Beachey EH.Epitopes of streptococcal M proteins shared with cardiac myosin . J Exp Med1985; 162: 583-591 .
15.
Krisher K , Cunningham MW.Myosin: a link between streptococci and heart . Science1985; 227: 413-415 .
16.
Goldstein I , Halpern B , Robert L.Immunological relationship between streptococcus A polysaccharide and the structural glycoproteins of heart valve . Nature1967; 213: 44-47 .
17.
Shikhman AR , Greenspan NS , Cunningham MW.A subset of mouse monoclonal antibodies cross-reactive with cytoskeletal proteins and group A streptococcal M proteins recognizes N-acetyl-beta-D-glucosamine . J Immunol1993; 151: 3902-3913 .
18.
Antone SM , Adderson EA , Mertens NMJ , Cunningham MW.Molecular analysis of V gene sequences encoding cytotoxic anti-streptococcal/anti-myosin monoclonal antibody 36.2.2 that recognizes the heart cell surface protein laminin . J Immunol1967; 159: 5422-5430 .
19.
Galvin JE , Hemric ME , Ward K , Cunningham MW.Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin . J Clin Invest2000; 106: 217-224 .
Cervera R , Piette JC , Font Jet al.Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients . Arthritis Rheum2002; 46: 1019-1027 .
23.
Cervera R , Khamashta MA , Font Jet al.High prevalence of significant heart valve lesions in patients with the primary antiphospholipid syndrome . Lupus1991; 1: 43-47 .
24.
Hojnik M , George J , Ziporen L , Shoenfeld Y.Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome . Circulation1996; 93: 1579-1587 .
25.
Libman E , Sacks BA.Hitherto undescribed from of valvular and mural endocarditis . Arc Intern Med1924; 33: 701-737 .
26.
Shapiro RF , Gamble CN , Weisner KB.Immunoparhogenesis of Libman-Sacks endocarditis . Ann Rheum Dis1977; 36: 508-516 .
27.
Asherson RA , Hudhes GRV.The expanding spectrum of Libman-Sacks endocarditis; the role of anti-phospholipid antibodies . Clin Exp Rheumatol1989; 7: 225-228 .
28.
Chartash EK , Lans DM , Paget SA , Qamar T , Lockshin MD.Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome . Am J Med1989; 86: 407-412 .
29.
Khamashta MA , Gil A , Asherson RA , Vazques JJ , Hughes GRV.Antiphospholipid antibodies, valvular heart disease, and systemic lupus erythematosus . Am J Med1989; 86: 633-634 .
30.
Ziporen L , Goldberg I , Arad Met al.Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves . Lupus1996; 5: 196-205 .
31.
Afek A , Shoenfeld Y , Manor Ret al.Increased endothelial cell expression of alpha3beta1 integrin in cardiac valvulopathy in the primary (Hughes) and secondary antiphospholipid syndrome . Lupus1999; 8: 502-507 .
32.
Blank M , Shoenfeld Y , Cabilli S , Heldman Y , Fridkin M , Katchalski-Katzir E.Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides . Proc Natl Acd Sci1999; 96: 5164-5168 .
33.
Blank M , Shani A , Goldberg Iet al.Libman-Sacks endocarditis associated with antiphospholipid syndrome and infection . Thromb Res2004; 114: 589-592 .
34.
Blank M , Krause I , Fridkin Met al.Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome . J Clin Invest2002; 109: 797-804 .
35.
Blank M , Asherson RA , Cervera R , Shoenfeld Y.Antiphospholipid syndrome infectious origin . J Clin Immunol2004; 24: 12-23 .
36.
Amital H , Langevitz P , Levy Yet al.Valvular deposition of antiphospholipid antibodies in the antiphospholipid syndrome: a clue to the origin of the disease . Clin Exp Rheumatol1999; 17: 99-102 .
37.
Nesher G , Ilany J , Rosenmann D , Abraham AS.Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment . Semin Arthritis Rheum1997; 27: 27-35 .
38.
Sanchez ML , Katsumata K , Atsumi Tet al.Association of HLA-DM polymorphism with the production of antiphospholipid antibodies . Ann Rheum Dis2004; 63: 1645-1648 .
